Cardiovascular disease prevention

Area of Science:

• Cardiology
• Preventive Medicine
• Public Health

Background:

• Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
• Effective risk reduction strategies are crucial for improving patient outcomes.
• Current guidelines emphasize risk factor assessment and management.

Purpose of the Study:

• To review the essential steps for effective cardiovascular disease (CVD) risk reduction.
• To detail the process of individual CVD risk assessment in a clinical setting.
• To discuss the management of major modifiable CVD risk factors.

Main Methods:

• Review of established guidelines and literature on CVD risk assessment.
• Analysis of key modifiable risk factors: hypertension, dyslipidemia, diabetes mellitus, and smoking.
• Discussion of emerging risk factors and supplementary non-invasive testing.
• Examination of global and local barriers to effective CVD risk factor treatment.

Main Results:

• Individual CVD risk assessment integrates current disease status, risk factor count, and absolute risk calculation.
• Management involves setting goals for modifiable risk factors through lifestyle changes and pharmacotherapy.
• Emerging risk factors and additional testing can refine risk stratification in select cases.
• Significant barriers exist at both global and local levels, hindering effective CVD risk factor management.

Conclusions:

• A systematic approach to CVD risk assessment and management is fundamental for effective risk reduction.
• Addressing modifiable risk factors comprehensively is key to preventing cardiovascular events.
• Overcoming implementation barriers is essential for widespread success in CVD risk factor control.